Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study

BACKGROUND: The immunogenicity and safety of a booster dose of tetanus toxoid-conjugate quadrivalent meningococcal vaccine (MenACYW-TT), alone or co-administered with MenB vaccine, were assessed in healthy 13–25-year olds who received MenACYW-TT or a CRM-conjugate vaccine (MCV4-CRM) 3–6 years earlie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambrano, Betzana, Peterson, James, Deseda, Carmen, Julien, Katie, Spiegel, Craig A., Seyler, Clifford, Simon, Michael, Hoki, Robert, Anderson, Marc, Brabec, Brad, Áñez, Germán, Shi, Jiayuan, Pan, Judy, Hagenbach, Audrey, Von Barbier, Dalia, Varghese, Kucku, Jordanov, Emilia, Dhingra, Mandeep Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000353/
https://www.ncbi.nlm.nih.gov/pubmed/36899125
http://dx.doi.org/10.1038/s41390-023-02478-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000353/
https://www.ncbi.nlm.nih.gov/pubmed/36899125
http://dx.doi.org/10.1038/s41390-023-02478-5

Ejemplares similares